Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander M Horspool

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Msphere|January 21, 2021
Interplay of Antibody and Cytokine Production Reveals CXCL13 as a Potential Novel Biomarker of Lethal SARS-CoV-2 InfectionAlexander M Horspool, Theodore Kieffer, Brynnan P Russ, et al.
Infection and Immunity|June 14, 2021
Reinvestigating the Coughing Rat Model of Pertussis To Understand <i>Bordetella pertussis</i> PathogenesisJesse M Hall, Jason Kang, Sophia M Kenney, et al.
Medrxiv : the Preprint Server for Health Sciences|August 24, 2021
Serological survey of SARS-CoV-2 incidence conducted at a rural West Virginia hospitalAlexander M Horspool, Brynnan P Russ, M Allison Wolf, et al.
Biorxiv : the Preprint Server for Biology|May 11, 2021
SARS-CoV-2 B.1.1.7 and B.1.351 variants of concern induce lethal disease in K18-hACE2 transgenic mice despite convalescent plasma therapyAlexander M Horspool, Chengjin Ye, Ting Y Wong, et al.
Plos One|August 29, 2022
SARS-CoV-2 Delta variant induces enhanced pathology and inflammatory responses in K18-hACE2 miceKatherine S Lee, Ting Y Wong, Brynnan P Russ, et al.
NPJ Vaccines|March 15, 2022
Intranasal administration of BReC-CoV-2 COVID-19 vaccine protects K18-hACE2 mice against lethal SARS-CoV-2 challengeTing Y Wong, Katherine S Lee, Brynnan P Russ, et al.
Journal of Virology|January 26, 2022
Evaluating Antibody Mediated Protection against Alpha, Beta, and Delta SARS-CoV-2 Variants of Concern in K18-hACE2 Transgenic MiceTing Y Wong, Alexander M Horspool, Brynnan P Russ, et al.
Frontiers in Cellular and Infection Microbiology|May 1, 2023
Development of an anti-<i>Pseudomonas aeruginosa</i> therapeutic monoclonal antibody WVDC-5244Alexander M Horspool, Emel Sen-Kilic, Aaron C Malkowski, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Msphere|January 21, 2021
Interplay of Antibody and Cytokine Production Reveals CXCL13 as a Potential Novel Biomarker of Lethal SARS-CoV-2 InfectionAlexander M Horspool, Theodore Kieffer, Brynnan P Russ, et al.
Infection and Immunity|June 14, 2021
Reinvestigating the Coughing Rat Model of Pertussis To Understand <i>Bordetella pertussis</i> PathogenesisJesse M Hall, Jason Kang, Sophia M Kenney, et al.
Medrxiv : the Preprint Server for Health Sciences|August 24, 2021
Serological survey of SARS-CoV-2 incidence conducted at a rural West Virginia hospitalAlexander M Horspool, Brynnan P Russ, M Allison Wolf, et al.
Biorxiv : the Preprint Server for Biology|May 11, 2021
SARS-CoV-2 B.1.1.7 and B.1.351 variants of concern induce lethal disease in K18-hACE2 transgenic mice despite convalescent plasma therapyAlexander M Horspool, Chengjin Ye, Ting Y Wong, et al.
Plos One|August 29, 2022
SARS-CoV-2 Delta variant induces enhanced pathology and inflammatory responses in K18-hACE2 miceKatherine S Lee, Ting Y Wong, Brynnan P Russ, et al.
NPJ Vaccines|March 15, 2022
Intranasal administration of BReC-CoV-2 COVID-19 vaccine protects K18-hACE2 mice against lethal SARS-CoV-2 challengeTing Y Wong, Katherine S Lee, Brynnan P Russ, et al.
Journal of Virology|January 26, 2022
Evaluating Antibody Mediated Protection against Alpha, Beta, and Delta SARS-CoV-2 Variants of Concern in K18-hACE2 Transgenic MiceTing Y Wong, Alexander M Horspool, Brynnan P Russ, et al.
Frontiers in Cellular and Infection Microbiology|May 1, 2023
Development of an anti-<i>Pseudomonas aeruginosa</i> therapeutic monoclonal antibody WVDC-5244Alexander M Horspool, Emel Sen-Kilic, Aaron C Malkowski, et al.
Pageof 2